Cargando…
Verproside, the Most Active Ingredient in YPL-001 Isolated from Pseudolysimachion rotundum var. subintegrum, Decreases Inflammatory Response by Inhibiting PKCδ Activation in Human Lung Epithelial Cells
Chronic obstructive pulmonary disease (COPD) is a chronic inflammatory lung disease which causes breathing problems. YPL-001, consisting of six iridoids, has potent inhibitory efficacy against COPD. Although YPL-001 has completed clinical trial phase 2a as a natural drug for COPD treatment, the most...
Autores principales: | Oh, Eun Sol, Ryu, Hyung Won, Kim, Mun-Ock, Lee, Jae-Won, Song, Yu Na, Park, Ji-Yoon, Kim, Doo-Young, Ro, Hyunju, Lee, Jinhyuk, Kim, Tae-Don, Hong, Sung-Tae, Lee, Su Ui, Oh, Sei-Ryang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10138391/ https://www.ncbi.nlm.nih.gov/pubmed/37108390 http://dx.doi.org/10.3390/ijms24087229 |
Ejemplares similares
-
Potent inhibition of human tyrosinase inhibitor by verproside from the whole plant of Pseudolysimachion
rotundum var. subintegrum
por: Jung, Sunin, et al.
Publicado: (2023) -
Verminoside from Pseudolysimachion rotundum var. subintegrum sensitizes cisplatin-resistant cancer cells and suppresses metastatic growth of human breast cancer
por: Lee, Changhu, et al.
Publicado: (2020) -
Picroside II Isolated from Pseudolysimachion rotundum var. subintegrum Inhibits Glucocorticoid Refractory Serum Amyloid A (SAA) Expression and SAA-induced IL-33 Secretion
por: Lee, Kiram, et al.
Publicado: (2019) -
In Vitro and in Vivo Metabolism of Verproside in Rats
por: Kim, Min Gi, et al.
Publicado: (2012) -
Compound K ameliorates airway inflammation and mucus secretion through the regulation of PKC signaling in vitro and in vivo
por: Lee, Jae-Won, et al.
Publicado: (2022)